Working Group Meeting, April 30 - May 1, 2007 Agenda
This website is archived for historical purposes and is no longer being maintained or updated.
Hilton Garden Inn Atlanta Airport / Millenium Center - Atlanta, GA
Please note that the Open Session for this meeting will be on Monday, April 30 from
4-5pm and Tuesday, May 1, rather than the usual time on Monday.
This meeting will be in Closed Session from 9:45 am- 4:00 pm on Monday, April 30.
Monday, April 30 | ||
---|---|---|
Time | Activity | Speaker |
9:30 - 9:45 | Welcome – Opening Remarks | Dr. Muin Khoury Dr. Kathleen Toomey |
9:45 - 10:00 | Closed Session called to order | Al Berg, Chair |
10:00 - 12:15 | Ongoing and new evidence review planning | WG Members, Staff & Consultants |
12:15 - 1:15 | Lunch Discussion: Review of Genetic Tests |
Dr. Bob Becker, FDA |
1:15 - 3:00 | Working Group discussion of Draft Recommendations | WG Members |
3:00 - 3:15 | Break | |
3:15 – 4:00 | Continuing Working Group discussion Closed session adjourned |
|
4:00 – 4:30 | Open Session called to order Report on Planning Meeting for Stakeholder Group (SAGE) |
Linda Bradley Toby Citrin |
4:30 – 5:00 | Wrap-up and Adjourn Closed Session | Al Berg, Chair |
Tuesday, May 1 | ||
---|---|---|
Time | Activity | Speaker |
8:00 – 9:00 | Executive Session - Working Group Members only | Al Berg |
The meeting will be Open Session from 9:00am to 2:00pm on Tuesday, May 1 | ||
9:00 – 9:30 | Open session called to order Overview of Day 1 and outstanding questions |
Al Berg, Chair & Staff |
9:30 – 10:00 | Staff Updates on EGAPP Activities | Linda Bradley & Michael Douglas |
10:15 – 10:45 | Break | |
10:45 – 11:30 | Products Subcommittee Report | Celia Kaye |
11:30 - 12:15 | Topics Subcommittee Report | Joan Scott |
12:15 - 1:00 |
Working Lunch
|
Steve Teutsch |
1:00 – 1:45 | Methods Subcommittee Report | Steve Teutsch |
1:45 - 2:00 | Wrap-up and Action Items | Al Berg, Chair Linda Bradley |
2:00 |
Adjourn Open Session | Al Berg, Chair |
- Page last reviewed: October 12, 2013 (archived document)
- Content source:
- Centers for Disease Control and Prevention
- Page maintained by: Office of Associate Director of Communication, Division of Public Affairs